Zyclara
Generic Name: imiquimod
Date of Approval: March 25, 2010
Company: Graceway Pharmaceuticals, LLC
Treatment for: Actinic Keratosis
FDA Approves Zyclara Cream
The United States Food and Drug Administration (FDA) has approved Zyclara (imiquimod) for the treatment of clinically typical, visible or palpable actinic keratoses (AK). The new treatment can be used on large areas of skin, including the full face or balding scalp on a convenient, 6-week dosing cycle.
Zyclara Patient Information
IMPORTANT: For use on the skin only (topical). Do not use Zyclara Cream in or on your eyes, nostrils, mouth or vagina.
